Clinical Research, Genetic Disease and Genotype

Why early participant engagement is now a top priority in genetic disease research

pharmaphorum

JANUARY 18, 2023

Pharmaceutical companies and biotechs are also adapting their approaches, launching patient finding and engagement programmes that can start years before clinical trials begin and allow them to run ‘recontact by genotype’ studies that the Resilience Project would have liked to do. Giving participants something in return.

Genetic Disease

Genetic Disease Genetics Research Genomics

10 Key Learnings from Successful Cellular and Gene Therapy Trials for Rare Diseases

XTalks

APRIL 24, 2023

Rare diseases can often be progressive, chronic and fatal. Approximately 72 percent of rare diseases are genetic, and around 70 percent of rare genetic diseases emerge in childhood. Sadly, one-third of children with rare diseases die before their first birthday.

Gene Therapy

Gene Therapy Gene Trials Clinical Trials

Clinical Research Informer

Why early participant engagement is now a top priority in genetic disease research

10 Key Learnings from Successful Cellular and Gene Therapy Trials for Rare Diseases

Webinars

Stay Connected